Pfizer CEO Albert Bourla joined President Trump at the White House last year on Sept. 30 to announce a voluntary agrreement to reduce some prescription drug prices. One element aimed to lower prices in the taxpayer-funded Medicaid program, but the program is still being built, and details about which drugs will be discounted remain under
